Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis

Angioimmunoblastic T‐cell lymphoma (AITL) is genetically characterized by TET2 and DNMT3A mutations occurring in haematopoietic progenitor cells, and late events (e.g. the RHOA‐G17V mutation) associated with malignant transformation. As TET2/DNMT3A‐mutated progenitor cells can differentiate into multilineage progenies and give rise to both AITL and myeloid neoplasms, they may also have the potential to lead to other metachronous/synchronous neoplasms. We report two cases showing parallel evolution of two distinct potentially neoplastic lymphoid proliferations from a common mutated haematopoietic progenitor cell population.

[1]  J. Cerhan,et al.  High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL) , 2021, Leukemia.

[2]  G. Follows,et al.  Early detection of T-cell lymphoma with T follicular helper phenotype by RHOA mutation analysis , 2021, Haematologica.

[3]  S. Chiba,et al.  Advances in understanding of angioimmunoblastic T-cell lymphoma , 2020, Leukemia.

[4]  J. Tardif,et al.  High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential. , 2020, Blood advances.

[5]  M. Arcila,et al.  Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms. , 2020, Blood advances.

[6]  G. Follows,et al.  Angioimmunoblastic T‐cell lymphoma contains multiple clonal T‐cell populations derived from a common TET2 mutant progenitor cell , 2019, The Journal of pathology.

[7]  B. Falini,et al.  High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML. , 2018, The New England journal of medicine.

[8]  J. Aster,et al.  RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice. , 2018, Blood.

[9]  S. Barrans,et al.  Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality , 2018, Laboratory Investigation.

[10]  A. Tzankov,et al.  High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations , 2018, Leukemia.

[11]  A. Ferrando,et al.  RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis. , 2018, Cancer cell.

[12]  B. Taylor,et al.  Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS , 2017, Nature.

[13]  R. Küppers,et al.  TET2 mutations in B cells of patients affected by angioimmunoblastic T‐cell lymphoma , 2017, The Journal of pathology.

[14]  P. Gaulard,et al.  The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development , 2016, Proceedings of the National Academy of Sciences.

[15]  M. Takei,et al.  A Clinicopathologic Study of Lennert Lymphoma and Possible Prognostic Factors: The Importance of Follicular Helper T-cell Markers and the Association With Angioimmunoblastic T-cell Lymphoma , 2016, The American journal of surgical pathology.

[16]  T. Molina,et al.  Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets , 2015, Haematologica.

[17]  P. Gaulard,et al.  The microenvironment in T-cell lymphomas: emerging themes. , 2014, Seminars in cancer biology.

[18]  O. Nureki,et al.  Somatic RHOA mutation in angioimmunoblastic T cell lymphoma , 2014, Nature Genetics.

[19]  W. Klapper,et al.  Peripheral T‐cell and NK‐cell lymphomas and their mimics; taking a step forward – report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology , 2014, Histopathology.

[20]  Mithat Gonen,et al.  Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis , 2012, Nature Genetics.

[21]  P. Opolon,et al.  TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.

[22]  J. Licht,et al.  DNMT3A mutations in acute myeloid leukemia , 2011, Nature Genetics.

[23]  B. Nathwani,et al.  Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. , 2011, Blood.

[24]  Sheng-Tsung Chang,et al.  Angioimmunoblastic T-cell lymphoma of cytotoxic T-cell phenotype containing a large B-cell proliferation with an undersized B-cell clonal product. , 2010, Applied immunohistochemistry & molecular morphology : AIMM.

[25]  D. Gilliland,et al.  Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. , 2009, Blood.

[26]  W. Erber,et al.  A practical strategy for the routine use of BIOMED‐2 PCR assays for detection of B‐ and T‐cell clonality in diagnostic haematopathology , 2007, British journal of haematology.

[27]  P. Gaulard,et al.  Histologic Evolution of Angioimmunoblastic T-cell Lymphoma in Consecutive Biopsies: Clinical Correlation and Insights Into Natural History and Disease Progression , 2007, The American journal of surgical pathology.

[28]  M. Du,et al.  Distinguishing angioimmunoblastic T‐cell lymphoma from peripheral T‐cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics , 2007, Histopathology.